Menu Search
Equities

Warby Parker Inc

WRBY:NYQ

Warby Parker Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)19.51
  • Today's Change0.20 / 1.04%
  • Shares traded2.53m
  • 1 Year change+79.48%
  • Beta--
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Warby Parker Inc grew revenues 11.98% from 598.11m to 669.77m while net income improved from a loss of 110.39m to a smaller loss of 63.20m.
Gross margin55.32%
Net profit margin-4.39%
Operating margin-5.69%
Return on assets-5.37%
Return on equity-10.15%
Return on investment-6.78%
More ▼

Cash flow in USDView more

In 2023, Warby Parker Inc did not generate a significant amount of cash. However, the company earned 60.99m from its operations for a Cash Flow Margin of 9.11%. In addition the company generated 2.87m cash from financing while 54.67m was spent on investing.
Cash flow per share0.0948
Price/Cash flow per share206.12
Book value per share2.80
Tangible book value per share2.80
More ▼

Balance sheet in USDView more

Warby Parker Inc uses little or no debt in its capital structure.
Current ratio2.47
Quick ratio2.06
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.